|
|
|
|
|
|
|
05.02.26 - 20:48
|
Das von Stripe-Veteranen gegründete Unternehmen Duna sammelt 30 Millionen Euro Kapital in einer von CapitalG angeführten Serie-A-Finanzierungsrunde ein, um das Problem der Geschäftsidentität im Internet zu lösen (Business Wire)
|
|
|
AMSTERDAM UND BERLIN--(BUSINESS WIRE)--Duna, das von zwei ehemaligen Stripe-Mitarbeitern gegründete Fintech für Identitätsmanagement, hat heute den Abschluss einer Serie-A-Finanzierungsrunde in Höhe von 30 Millionen Euro unter der Leitung von CapitalG, dem unabhängigen Wachstumsfonds von Alphabet, bekannt gegeben. Die bestehenden Investoren Index Ventures, Puzzle Ventures und Frank Slootman, Chairman von Snowflake, haben sich ebenfalls an der Runde beteiligt.
Das in Deutschland und den Niederlanden ansässige Unternehmen wurde 2023 von Duco van Lanschot, der drei Jahre lang Head of Benelux and DACH bei Stripe war, und David Schreiber, der sechs Jahre bei Stripe für den größten globalen Geschäftsbereich des Unternehmens inklusive der zentralen Kartenzahlungsplattform verantwortlich war, gegründet. Im Mai 2025 kündigte das Unternehmen eine von Index Ventures angeführte Startkapitalrunde mit einem Volumen von 10,7 Millionen Euro an. Nach der jüngsten Finanzierungsrunde beläuft sich das Gesamtka...
|
|
|
05.02.26 - 15:06
|
Duna, Built by Stripe Veterans, Raises €30 Million CapitalG-led Series A to Solve Business Identity For The Internet (Business Wire)
|
|
|
AMSTERDAM & BERLIN--(BUSINESS WIRE)--Duna, the identity fintech founded by two Stripe alumni, today announced a €30 million Series A funding round led by CapitalG, Alphabet's independent growth fund. Existing investors Index Ventures, Puzzle Ventures and Snowflake Chairman Frank Slootman also participated in the round.
The company, based in Germany and the Netherlands, was launched in 2023 by Duco van Lanschot, who was head of Benelux and DACH at Stripe for three years, and David Schreiber, who spent six years at Stripe where he ran the company's largest global business unit, including the core card payment platform. In May 2025, the company announced a €10.7 million seed round led by Index Ventures. The latest fundraise brings Duna's total funding to more than €40 million.
Duna's mission is to build global trust infrastructure by providing a digital passport for every business. Over time, this will evolve into a network for shareable identity and one-click onboarding. Today Duna's AI-native bu...
|
|
|
|
|
|
|
|
|
|
|
|
|
25.03.25 - 09:00
|
Hansa Biopharma to attend Van Lanschot Kempen Life Sciences Conference (Cision)
|
|
|
Lund, Sweden, 25 March 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced it will attend Van Lanschot Kempen Life Sciences Conference in Amsterdam, NL, on 2-3 April. Hansa management will be available for meetings at the conference. If you are interested in meeting with the management team, please contact Hansa Biopharma at ir@hansabiopharma.com.
To learn more about Hansa Biopharma see the latest Corporate Presentation here. (https://www.hansabiopharma.com/investors/presentations-events/) The Company's year-end financial report can be found here (https://www....
|
|
|
|
|
|
|
|
|
|
|
|
|
03.03.25 - 07:48
|
ING Acquires Stake In Van Lanschot Kempen (AFX)
|
|
|
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - ING has reached an agreement with Reggeborgh Groep on the acquisition of a 17.6% stake in Van Lanschot Kempen N.V. Together with an existing 2.7% stake, ING wi......
|
|
|
03.03.25 - 07:03
|
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences (GlobeNewswire EN)
|
|
|
Saint-Herblain (France), March 3, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announced that its senior management will participate at upcoming investor conferences in the United States and Europe. CEO Thomas Lingelbach and CFO Peter Bühler will present at the TD Cowen 45th Annual Health Care Conference, taking place March 3 - 5, 2025, in Boston, MA. Mr. Lingelbach and Mr. Peter Bühler will also meet with institutional investors during the Van Lanschot Kempen Life Sciences Conference, held April 2 - 3, 2025, in Amsterdam, The Netherlands....
|
|